Green and biocompatible formulation of arbutin encapsulated alginate nanoparticle: improved cytotoxicity against melanoma cancer and potent inhibition of melanin biosynthesis and L-DOPA auto-oxidation
Authors:
- Mahmoud OmidiMOMahmoud Omidi
- Nikoo Ghasabeh Siahkal-MahalehNSNikoo Ghasabeh Siahkal-Mahaleh
- Seyyed Mobin RahimniaSRSeyyed Mobin Rahimnia
- Manouchehr JandaghiMJManouchehr Jandaghi
- Mojtaba Shabani-BorujeniMSMojtaba Shabani-Borujeni
- Esmaeil MohammadianEMEsmaeil Mohammadian
- Seyyed Mohammad Hassan HashemiSHSeyyed Mohammad Hassan Hashemi
- 28 January 2026
- journal article
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 37 (16) , 3047-3065
Abstract
The elevated melanin production within the skin results in a distressing pigmentation disorder called melanoma. This underscores the importance of developing effective therapeutic approaches, such as nano-delivery systems. The primary objective of this research was to create alginate (AL) nanoparticle (NP) in gel dosage for improving targeting of arbutin (ARB) as a lightening substance to cure and manage melanoma cancer. Ionic gelation and ultrasonication method were employed to prepare ARB-AL-NP followed by In-vitro assessment of the NP. Outcomes noticed that the optimum ARB-AL-NP were in the size of 252.333 ± 11.873 nm with zeta potential -14.766 ± 0.862, greater encapsulation 89.831 ± 1.081%, and exhibited sustained release of ARB over 6 h (56%). In vitro MTT analysis confirmed that the optimum formulation had higher cell survival on the HFF cell line than kojic-acid and ARB, however, it showed a greater cytotoxic effect on the B16f10 cell line than other groups. Besides, ARB-AL-NP was established to obstruct melanogenesis to a superior level than kojic-acid and ARB and considerably suppress L-dopa auto-oxidation contrasted to kojic-acid and ARB). The outcomes of this assessment confirmed that the ARB-AL-NP could potentially serve as a prospective nanocarrier for ARB cutaneous application, thus unveiling novel approaches for addressing melanoma complaints.Keywords
Funding Information
- Hormozgan University of Medical Sciences (4020044)
This publication has 38 references indexed in Scilit:
- Effects of nanoparticle size, shape, and zeta potential on drug deliveryInternational Journal of Pharmaceutics, 2024
- 3D-printed Laponite/Alginate hydrogel-based suppositories for versatile drug loading and releaseDrug Delivery and Translational Research, 2024
- Sodium Alginate as a Pharmaceutical Excipient: Novel Applications of a Well-known PolymerJournal of Pharmaceutical Sciences, 2022
- Alginate hydrogel: The influence of the hardening on the rheological behaviourJournal of the Mechanical Behavior of Biomedical Materials, 2021
- The dark side of skin lightening: An international collaboration and review of a public health issue affecting dermatologyInternational Journal of Women's Dermatology, 2021
- Nanoparticle-based drug delivery systems for cancer therapySmart Materials in Medicine, 2020
- Size‐Dependent EPR Effect of Polymeric Nanoparticles on Tumor TargetingAdvanced Healthcare Materials, 2019
- Tailor made alginate hydrogel for local infection prophylaxis in orthopedic applicationsMaterials Science and Engineering: C, 2017
- Polymeric formulations for drug release prepared by hot melt extrusion: application and characterizationDrug Discovery Today, 2015
- Inhibitory effects of arbutin on melanin biosynthesis of α-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissuesArchives of Pharmacal Research, 2009